Paracetamol Misuse and Dental Pain: Results from the French Observational DAntaLor Study

Aims: To evaluate the risk of hepatotoxicity due to unintentional paracetamol misuse in patients with acute dental pain. Methods: A prospective multicenter observational survey was performed in patients consulting, without appointment, the odontology departments of three main French hospitals in the Lorraine region over a 3-month period. Patients were asked to fill out a medical questionnaire while seated in the waiting room. Those who completed the questionnaire, had dental pain, and took paracetamol were included in the DAntaLor study. Misuse was defined as a daily dose of more than 4 g of paracetamol per day. The risk of hepatotoxicity was considered high if the supposed ingested dose was above the threshold of 150 mg.kg-1.24h-1, 125 mg.kg-1.24h-1, or 100 mg.kg-1.24h-1 over periods of 24, 48, and 72 hours, respectively. Hepatotoxicity was suspected in the presence of clinical symptoms. Results: Of the 1,810 patients consulting the odontology departments, 741 were included in the study. Painkillers were used in 74.4% of the cases, and paracetamol was taken by 81.7%. Paracetamol was self-medicated in 85.5% of the patients and misused by 6.0%. Clinical symptoms were observed in 1.6% of the patients with no paracetamol misuse. For patients consuming more than 4 g per day and experiencing mild unspecific clinical symptoms of hepatotoxicity, the suspected ingested dose category was below one of the three previously defined thresholds for 11.8% and was above for 40.0%. Conclusion: Patients with dental pain are at risk of paracetamol overdose and hepatotoxicity.

acetaminophen;acute dental pain;misuse;paracetamol;unintentional intoxication

1.Agence Nationale de Sécurité de Médicament et des Produits de Santé (ANSM). Analyse des ventes de médicaments en France en 2011. ANSM: 2012. https://ansm.sante.fr/var/ansm_site/storage/original/application/0e689f733291d5ddbb09f0cccf93e438.pdf. Accessed 16 November, 2018.

2.Tittarelli R, Pellegrini M, Scarpellini MG, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci 2017;21(1 suppl):s95–s101.

3.Hargreaves K, Abbott PV. Drugs for pain management in dentistry. Aust Dent J 2005;50(4 suppl 2):s14–s22.

4.Thomas MB, Moran N, Smart K, Crean S. Paracetamol overdose as a result of dental pain requiring medical treatment—Two case reports. Br Dent J 2007;203:25–28.

5.Heard KJ, Ries NL, Dart RC, Bogdan GM, Zallen RD, Daly F. Overuse of non-prescription analgesics by dental clinic patients. BMC Oral Health 2008;8:33.

6.Matusiak R, Harley KE. Paracetamol overdose in a teenager following placement of a fixed appliance. Dent Update 2009; 36:33–35.

7.Vogel J, Heard KJ, Carlson C, Lange C, Mitchell G. Dental pain as a risk factor for accidental acetaminophen overdose:A case-control study. Am J Emerg Med 2011;29:1125–1129.

8.Siddique I, Mahmood H, Mohammed-Ali R. Paracetamol overdose secondary to dental pain: A case series. Br Dent J 2015;219:E6.

9.Clement C, Scala-Bertola J, Javot L, et al. Misuse of acetaminophen in the management of dental pain. Pharmacoepidemiol Drug Saf 2011;20:996–1000.

10.Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: A comprehensive update. J Clin Transl Hepatol 2016;4:131–142.

11.Dargan PI, Ladhani S, Jones AL. Measuring plasma paracetamol concentrations in all patients with drug overdose or altered consciousness: Does it change outcome? Emerg Med J 2001;18:178–182.

12.Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA, Panel of Australian and New Zealand clinical toxicologists. Guidelines for the management of paracetamol poisoning in Australia and New Zealand—Explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008;188:296–301.

13.McCaffery M, Beebe A. Pain: Clinical Manual for Nursing Practice. London: Mosby, 1994.

14.Roger-Leroi V, Laléchère-Lestrade C, Tubert-Jeannin S. Characteristics of the patients needing emergency dental treatment at the hospital of Clermont-Ferrand (France) [in French]. Rev Epidemiol Sante Publique 2007;55:197–202.

15.Tramini P, Al Qadi Nassar B, Valcarcel J, Gibert P. Factors associated with the use of emergency dental care facilities in a French public hospital. Spec Care Dentist 2010;30:66–71.

16.Radeva E. Emergency treatment of irreversible pulpitis. J IMAB 2008;14:3–4.

17.McDougal RA, Delano EO, Caplan D, Sigurdsson A, Trope M. Success of an alternative for interim management of irreversible pulpitis. J Am Dent Assoc 2004;135:1707–1712.

18.Agence Nationale de Sécurité de Médicament et des Produits de Santé. Fiche d’aide à l’automédication : Le paracétamol en bref—Information patient. ANSM: 2008. http://ansm.sante.fr/var/ansm_site/storage/original/application/b69723fdab668e3ee857d2b4e4805382.pdf. Accessed 16 November, 2018.

19.Food and Drug Administration (FDA). Acetaminophen: Avoiding Liver Injury. US Food & Drug Administration, 2009. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm168830.htm. Accessed 16 November, 2018.

20.Know Your Dose Campaign. The Acetaminophen Awareness Coalition. KnowYourDose, 2017. http://www.knowyourdose.org/the-acetaminophen-awareness-coalition/. Accessed 16 November, 2018.

21.Food and Drug Administration (FDA). Medicines in My Home. US Food and Drug Administration, 2014. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/ucm092139.htm. 16 November, 2018.

22.Get Relief Responsibly. Adult acetaminophen dosage chart. McNeil Consumer Healthcare, 2016. https://www.getreliefresponsibly.com/use-pain-medicine-safely/adult-acetaminophen-dosing. Accessed 16 November, 2018.

23.Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial. JAMA 2006;296:87–93.

24.Heard K, Green JL, Anderson V, Bucher-Bartelson B, Dart RC. Paracetamol (acetaminophen) protein adduct concentrations during therapeutic dosing. Br J Clin Pharmacol 2016;81: 562–568.

25.McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 2013;30:2174–2187.

26.Cook SF, King AD, Chang Y, et al. Quantification of a biomarker of acetaminophen protein adducts in human serum by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry: Clinical and animal model applications. J Chromatogr B Analyt Technol Biomed Life Sci 2015;985:131–141.

27.Nayyer NV, Byers J, Marney C. Identifying adults at risk of paracetamol toxicity in the acute dental setting: Development of a clinical algorithm. Br Dent J 2014;216:229–235.

28.Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol 2007;17:643–653.